Related Experiment Video
Updated: Jan 25, 2026

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells
Published on: May 19, 2023
Limitations with in vitro production of dendritic cells using cytokines
Helen C ONeill1, Heather L Wilson
1School of Biochemistry and Molecular Biology, Faculty of Science, Australian National University, Canberra, Australia. Helen.ONeill@anu.edu.au
Abstract:
Dendritic cells (DC) are the most effective antigen-presenting cells. Many studies now show that DC can be generated in vitro from a number of starting cell populations containing hematopoietic precursors. The protocols used involve different combinations of cytokines including granulocyte macrophage-colony stimulating factor (GM-CSF), which supports myeloid precursors, or interleukin-7, which supports lymphoid precursors. DC are commonly generated by in vitro culture of bone marrow or monocytes with GM-CSF and other cytokines. However, these cultures do not sustain DC production for long periods of time and do not allow the identification or study of intermediate stages in cell development. In vitro cytokine-dependent cultures of DC precursors do provide a reliable source of DC for stimulating immune responses. However, use of cells produced in cytokine-dependent cultures for the study of DC differentiation is limited, as DC development in vivo differs in cytokine dependency.
Related Concept Videos
The Number e as a Limit
Limits to Natural Selection
Drug Product Performance: In Vitro–In Vivo Correlation
Limiting Reactant
Neurons: The Cell Body and the Dendrites
Central Limit Theorem
The sample size, n, that...

